Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.62 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.51 |
| ▸ | PIM1 | P11309 | 1/20 | 0.51 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.51 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.51 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.51 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5981956 | 1.00 | PNP (0.62) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL5981965 | 1.00 | PNP (0.62) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL5983887 | 0.88 | PNP (0.58) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL5982599 | 0.88 | PNP (0.58) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL5983879 | 0.88 | PNP (0.58) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL5983794 | 0.87 | PNP (0.72) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL5983803 | 0.87 | PNP (0.72) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL18098164 | 0.86 | PNP (0.66) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL6560259 | 0.85 | LMNA (0.79) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL5983804 | 0.85 | LMNA (0.79) | PNPLMNATP53HTTPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3512863-B1 | 2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR RNA VIRUS TREATMENT | ATEA PHARMACEUTICALS INC (US) | 2021-12-08 | — | — | EP | disclosed |